Facing patent expires, the original medicine how to build "moat"?

Predicts 2028, the Indian market will have the sales of $500 million of the original drug patent issue.At the appointed time, and how generics "rival", the greatest degree to keep market share?The original medicine to do not only pay close attention to stakeholders, dynamic and repricing, cooperation or authorized, product innovation and strategic considerations